PROXON®
According to WHO data:

- 47 million people suffer from dementia;

- by 2050 could be more than 140 million;

- public health problem
PROXON®
Develop specific nutraceuticals with the objective of:

- delay or prevent cognitive decline
PROXON®
- Citicoline (Cognizin™);

- Fusionpack™;

- SBS™;

- QNP™;

- LIPIDCaps™;

PROXON®
Several studies demonstrate improvements in:

- memory;

- learning;

- concentration.
PROXON®
Pack with 20 Fusionpack™
(20 ampoules + 20 capsules)

CNP: 7767616



PROXON®
How to use:

1) To use the Open-Flex system, hold the blister firmly in an upright position (tip up) and bend the extremity;

2) Pour the contents into a glass of water;

3) To remove the capsule from the blister, partially move the layer on the back of the blister using the “peel off” corner;

4) Take the capsule with a glass of water.

Take 1 Fusionpack™ per day (1 ampoule + 1 capsule).

In case of recommendation by a doctor or pharmacist, the dose may be increased to 2 Fusionpack™ per day (2 ampoules + 2 capsules).
PROXON®
Due to the lack of studies confirming the safety of use in case of pregnancy and breastfeeding, this supplement should not be used in these situations, unless indicated otherwise by your doctor or pharmacist.

The product should not be used in case of hypersensitivity, allergy and when there are known interactions between any ingredient of this formulation and other products.

This product contains citicoline (Cognizin™) and is not intended to be consumed by children.